Fundraising Overview - The company raised a total of RMB 756.77 million by issuing 16.1668 million shares at a price of RMB 46.81 per share, with net proceeds amounting to RMB 688.37 million after deducting various fees [2][3] - The funds were deposited into a dedicated fundraising account managed under specific regulatory agreements with banks and the underwriting institution [3][5] Fund Utilization and Management - The company has established a management system for the use of raised funds, ensuring they are stored in dedicated accounts and used efficiently to protect investor interests [3][4] - As of December 31, 2024, the company had four dedicated fundraising accounts, six large deposit accounts, and three structured deposit accounts [5] Fund Usage Details - The company approved the use of RMB 109.85 million of raised funds to replace pre-invested project funds and issuance costs, which was completed by May 2023 [5][6] - The company also utilized bank acceptance bills and self-owned funds for project financing, replacing RMB 26.82 million with raised funds [5][6] Idle Fund Management - The company plans to use up to RMB 3.5 billion of idle raised funds for cash management to enhance fund efficiency and returns, with a rolling investment period of up to 12 months [6][7] - As of December 31, 2024, there were RMB 144 million in large deposits and RMB 140 million in structured deposits that had not yet matured [7] Project Delays and Adjustments - Certain fundraising projects, such as the "Unloading Elevator R&D and Industrialization Project," have been postponed due to site implementation issues, with new expected completion dates set for February 2025 and February 2026 [9][10] - The company has not changed the investment projects or their funding usage, and there are no significant issues in the disclosure of fundraising usage [11][12] Financial Performance - In the first quarter of 2025, the company reported a revenue of RMB 52.09 million, a decrease of 37.47% year-on-year, attributed to reduced market demand and operational challenges [18] - The net profit attributable to shareholders was RMB 10.54 million, down 48.06% compared to the previous year, influenced by increased costs and reduced cash management income [18]

Core Viewpoint - Shenzhen Youxunda Technology Co., Ltd. has successfully managed and utilized its raised funds in accordance with regulatory requirements, reflecting a commitment to transparency and investor protection [1][2][3]. Fundraising Overview - The company raised a total of RMB 180.51 million through the public offering of 25 million shares at a price of RMB 8.46 per share on April 21, 2017 [1][2]. - As of December 31, 2024, the cumulative investment in fundraising projects amounted to RMB 190.63 million, with RMB 24.28 million specifically allocated for the construction of the Youxunda Wireless Sensor Network R&D Center [1][2]. Fund Management - The company has established special accounts for fundraising at multiple banks and has implemented strict approval procedures to ensure the funds are used for their intended purposes [2][3]. - The management system for fundraising was approved by the board in 2015 and is designed to comply with relevant laws and regulations [2]. Fund Usage in 2024 - The total amount of funds utilized in 2024 was RMB 24.28 million, with no reported violations in the management and usage of the funds [2][4]. - The company has not encountered any issues or discrepancies in the disclosure of fundraising usage [4]. Changes in Fund Investment Projects - The company has made adjustments to the use of raised funds, reallocating RMB 69.45 million originally intended for the "Youxunda Smart Grid Product Production Base" to the "Energy IoT R&D and Industrialization Base Project" in Wuhan [3][5]. - The decision to change the project locations and purposes was made in response to evolving business needs and regulatory environments, with all changes approved by the board and disclosed to shareholders [4][5]. Summary of Fund Usage - As of December 31, 2024, the balance in the fundraising special account was zero, indicating that all raised funds have been fully utilized [4][6]. - The company has maintained compliance with all regulatory requirements regarding the management and usage of the raised funds, ensuring that all disclosures are timely and accurate [4][6].

Core Viewpoint - The report provides a reasonable assurance conclusion regarding the use and storage of funds raised by Shanghai MicroPort EP Medical Technology Co., Ltd. for the year 2024, confirming compliance with relevant regulations and accurate reflection of the financial situation [2][4][5]. Fundraising Overview - The company raised a total of RMB 1,069,879,920.88 through the issuance of 70.6 million shares at a price of RMB 16.51 per share, with the funds verified by DaHua Accounting Firm [4][6]. - As of December 31, 2024, the total amount used from the raised funds was RMB 109,297,928.23, leaving a balance of RMB 687,376,885.41, which includes RMB 662,000,000.00 in bank wealth management products [4][8]. Fund Management - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and used strictly for designated projects, with regular audits conducted by the sponsor [5][6]. - The company signed tripartite and quadripartite agreements with banks to ensure proper oversight of the funds, which have been effectively implemented [5][6]. Fund Usage - The funds were allocated to various projects, including RMB 44,175,632.76 for the electrophysiological intervention medical device R&D project, RMB 1,407,722.00 for production base construction, and RMB 63,714,573.47 for marketing service system construction [4][8]. - The company has not used idle funds for temporary working capital or other non-designated projects during the year [6][12]. Project Adjustments - The company has made adjustments to its investment projects, including extending the timeline for the electrophysiological intervention medical device R&D project to December 2027 due to the addition of new sub-projects [14][17]. - The production base construction project has been optimized to reduce costs, with the total investment adjusted from RMB 29,949.49 million to RMB 7,578.92 million [15][17]. - The marketing service system project has seen an increase in investment from RMB 14,376.84 million to RMB 17,522.51 million to enhance market penetration and service capabilities [18][19].

江南新材: 中信证券股份有限公司关于江西江南新 材料科技股份有限公司使用募集资金向全资子公司 提供借款以实施募投项目的核查意见 中信证券股份有限公司 关于江西江南新材料科技股份有限公司使用募集资金 向全资子公司提供借款以实施募投项目的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为江西 江南新材料科技股份有限公司（以下简称"江南新材"或"公司"）首次公开发 行股票的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所 股票上市规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等有 关规定，对公司使用募集资金向全资子公司提供借款以实施募投项目的事项发表 核查意见如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意江西江南新材料科技股份有限公司 首次公开发行股票注册的批复》（证监许可〔2024〕1805 号）同意注册，并经上 海证券交易所同意，公司首次公开发行人民币普通股（A 股）3,643.63 万股，每 股面值 1 元，每股发行价格为人民币 10.54 元，募集资金总额为人民 ...

快意电梯: 年度募集资金使用鉴证报告 快意电梯股份有限公司 募集资金存放与实际使用情 况审核报告 大信专审字2025第 5-00009 号 大信会计师事务所（特殊普通合伙） WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 大信会计师事务所 WUYIGE Certified Public Accountants.LLP 电话 Telephone： +86（10）82330558 北京市海淀区知春路 1 号 Room 2206 22/F,Xueyuan International Tower 传真 Fax： +86（10）82327668 学院国际大厦 22 层 2206 No.1 Zhichun Road, Haidian Dist. 网址 Internet： www.daxincpa.com.cn 邮编 100083 Beijing,China,100083 募集资金存放与实际使用情况审核报告 大信专审字2025第 5-00009 号 快意电梯股份有限公司全体股东： 我们接受委托，对后附的快意电梯股份有限公司（以下简称"贵公司"）《2024年度募集 资金存放与实际使用情况的专 ...